Developmental defects and behavioral changes in a diet-induced inflammation model of zebrafish
- PMID: 36389790
- PMCID: PMC9643868
- DOI: 10.3389/fimmu.2022.1018768
Developmental defects and behavioral changes in a diet-induced inflammation model of zebrafish
Abstract
Soybean meal evokes diet-induced intestinal inflammation in certain fishes. Although the molecular aspects of soybean-induced intestinal inflammation in zebrafish are known, the impact of the inflammatory diet on fish behavior remain largely underexplored. We fed zebrafish larvae with three diets - control, soybean meal and soybean meal with β-glucan to gain deeper insight into the behavioral changes associated with the soybean meal-induced inflammation model. We assessed the effect of the diets on the locomotor behavior, morphological development, oxygen consumption and larval transcriptome. Our study revealed that dietary soybean meal can reduce the locomotor activity, induce developmental defects and increase the oxygen demand in zebrafish larvae. Transcriptomic analysis pointed to the suppression of genes linked to visual perception, organ development, phototransduction pathway and activation of genes linked to the steroid biosynthesis pathway. On the contrary, β-glucan, an anti-inflammatory feed additive, counteracted the behavioral and phenotypic changes linked to dietary soybean. Although we did not identify any differentially expressed genes from the soybean meal alone fed group vs soybean meal + β-glucan-fed group comparison, the unique genes from the comparisons of the two groups with the control likely indicate reduction in inflammatory cytokine signaling, inhibition of proteolysis and induction of epigenetic modifications by the dietary glucan. Furthermore, we found that feeding an inflammatory diet at the larval stage can lead to long-lasting developmental defects. In conclusion, our study reveals the extra-intestinal manifestations associated with soybean meal-induced inflammation model.
Keywords: behavior; inflammation; soybean meal; zebrafish; β-glucan.
Copyright © 2022 Rehman, Gora, Varshney, Dias, Olsvik, Fernandes, Brugman and Kiron.
Conflict of interest statement
Author JD was employed by company SPAROS Lda. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Yanartas O, Kani HT, Bicakci E, Kilic I, Banzragch M, Acikel C, et al. . The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease. Neuropsychiatr Dis Treat (2016) 12:673–83. doi: 10.2147/NDT.S106039 - DOI - PMC - PubMed
-
- van den Brink G, Stapersma L, El Marroun H, Henrichs J, Szigethy EM, Utens EM, Escher JC. Effectiveness of disease-specific cognitive–behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: Study protocol of a multicentre randomised controlled trial (HAPPY-IBD). BMJ Open Gastroenterol (2016) 3:e000071. doi: 10.1136/bmjgast-2015-000071 - DOI - PMC - PubMed
-
- Keefer L, Kane SV. Considering the bidirectional pathways between depression and IBD: Recommendations for comprehensive IBD care. Gastroenterol Hepatol (2017) 13:164–9. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439135/. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
